Free Trial

Victory Capital Management Inc. Sells 131,620 Shares of Delek US Holdings, Inc. (NYSE:DK)

Victory Capital Management Inc. cut its stake in shares of Delek US Holdings, Inc. (NYSE:DK - Free Report) by 5.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,507,019 shares of the oil and gas company's stock after selling 131,620 shares during the quarter. Victory Capital Management Inc. owned approximately 3.92% of Delek US worth $64,681,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. River Road Asset Management LLC raised its stake in Delek US by 510.1% during the 4th quarter. River Road Asset Management LLC now owns 3,747,111 shares of the oil and gas company's stock valued at $96,675,000 after purchasing an additional 3,132,971 shares during the period. International Assets Investment Management LLC lifted its holdings in shares of Delek US by 2,421.9% in the fourth quarter. International Assets Investment Management LLC now owns 937,785 shares of the oil and gas company's stock worth $24,195,000 after buying an additional 900,600 shares in the last quarter. UBS Group AG boosted its position in shares of Delek US by 3.6% during the third quarter. UBS Group AG now owns 719,310 shares of the oil and gas company's stock worth $20,436,000 after acquiring an additional 24,695 shares during the last quarter. Boston Partners grew its stake in Delek US by 0.5% during the third quarter. Boston Partners now owns 539,381 shares of the oil and gas company's stock valued at $15,153,000 after acquiring an additional 2,630 shares in the last quarter. Finally, Raymond James & Associates bought a new stake in Delek US in the 4th quarter valued at $13,295,000. 97.01% of the stock is owned by hedge funds and other institutional investors.


Insider Buying and Selling

In related news, CFO Robert G. Wright sold 2,123 shares of the business's stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $28.50, for a total transaction of $60,505.50. Following the transaction, the chief financial officer now directly owns 18,925 shares in the company, valued at $539,362.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold a total of 4,976 shares of company stock worth $141,243 in the last 90 days. Insiders own 1.80% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on DK shares. Scotiabank increased their price objective on shares of Delek US from $25.00 to $27.00 and gave the company a "sector perform" rating in a research report on Thursday, April 11th. Citigroup initiated coverage on Delek US in a research report on Wednesday, January 24th. They issued a "neutral" rating for the company. TD Cowen upped their price objective on Delek US from $23.00 to $24.00 and gave the company a "market perform" rating in a research report on Wednesday, February 28th. Mizuho lifted their target price on Delek US from $26.00 to $30.00 and gave the stock an "underperform" rating in a report on Friday, March 22nd. Finally, Wells Fargo & Company increased their price target on Delek US from $21.00 to $26.00 and gave the company an "underweight" rating in a report on Wednesday, March 20th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $28.56.

Check Out Our Latest Stock Report on DK

Delek US Stock Performance

Shares of NYSE:DK traded up $0.20 during trading on Friday, hitting $26.91. 733,707 shares of the stock traded hands, compared to its average volume of 890,038. The company has a fifty day moving average price of $29.10 and a two-hundred day moving average price of $27.44. Delek US Holdings, Inc. has a 52-week low of $19.39 and a 52-week high of $33.60. The company has a market cap of $1.72 billion, a price-to-earnings ratio of 122.32 and a beta of 1.34. The company has a quick ratio of 0.63, a current ratio of 0.99 and a debt-to-equity ratio of 2.66.

Delek US (NYSE:DK - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The oil and gas company reported ($1.46) earnings per share for the quarter, missing analysts' consensus estimates of ($1.28) by ($0.18). The firm had revenue of $4.05 billion during the quarter, compared to analyst estimates of $3.55 billion. Delek US had a return on equity of 18.27% and a net margin of 0.12%. The company's revenue was down 9.6% on a year-over-year basis. During the same quarter last year, the company posted $0.88 EPS. As a group, equities analysts predict that Delek US Holdings, Inc. will post 1.38 EPS for the current year.

Delek US Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 24th. Investors of record on Friday, May 17th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 3.72%. The ex-dividend date of this dividend is Thursday, May 16th. This is a positive change from Delek US's previous quarterly dividend of $0.25. Delek US's payout ratio is presently 445.45%.

Delek US Company Profile

(Free Report)

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.

See Also

Institutional Ownership by Quarter for Delek US (NYSE:DK)

→ Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad)

Should you invest $1,000 in Delek US right now?

Before you consider Delek US, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.

While Delek US currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: